Send to

Choose Destination
Memo. 2017;10(4):237-239. doi: 10.1007/s12254-017-0371-z. Epub 2017 Dec 5.

ASCO 2017-highlights of gynecological cancer.

Radl B1,2,3, Mlineritsch B1,2,3.

Author information

3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research and Center for Clinical Cancer and Immunology Trials, 5020 Salzburg, Austria.
Cancer Cluster Salzburg, 5020 Salzburg, Austria.


At this year's ASCO annual meeting several important studies in the field of gynecological cancer were presented. Here we report a personal selection of the most interesting and clinically relevant data.


Advanced cervical cancer; Lymphadenectomy; Maintenance therapy; Ovarian cancer; PARP inhibition

Conflict of interest statement

B. Radl and B. Mlineritsch declare that they have no competing interests.

Publication type

Publication type

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center